LOS ANGELES, Nov. 28, 2016 /PRNewswire/
-- StockNewsNow.com, The Official MicroCap News Source™, today
published an SNNLive Newscast with Pamela
Pavco, Ph.D., Chief Development Officer for RXi
Pharmaceuticals Corporation (NASDAQ: RXII) a clinical-stage company
developing therapeutics that address unmet medical needs, according
to the company's website (see here: www.rxipharma.com). The video
interview was recorded on Monday, November
14th, 2016 via Skype from SNN's office in Los Angeles, CA and RXi's headquarters in
Marlborough, MA.
Click the following link to watch the SNNLive Newscast™ Video
Interview on StockNewsNow.com:
Update with RXi Pharmaceuticals Corporation – Competitive
Advantage, Goals and Milestones for 2016-2017
You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN,
YOUTUBE, and STOCKTWITS
Please review important disclosures on our website at:
http://stocknewsnow.com/legal.php#disclaimer
About RXi Pharmaceuticals Corporation
RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a
clinical-stage company developing innovative therapeutics that
address significant unmet medical needs. Building on the
pioneering discovery of RNAi, the Company's discovery and clinical
development programs are based on its proprietary self-delivering
RNAi (sd-rxRNA®) platform and Samcyprone™, a small molecule topical
immunomodulator. Current clinical development programs include
RXI-109, an sd-rxRNA, for the treatment of dermal and ocular
scarring, and Samcyprone™ for the treatment of such disorders as
warts, alopecia areata, non-malignant skin tumors and cutaneous
metastases of melanoma. RXi's robust pipeline, coupled with
an extensive patent portfolio, provides for multiple product and
business development opportunities across a broad spectrum of
therapeutic areas. We are committed to being a partner of choice
for academia, small companies, and large multinationals. We welcome
ideas and proposals for strategic alliances, including in- and
out-licensing opportunities, to advance and further develop
strategic areas of interest. For company description and additional
information may be found on the Company's
website, www.rxipharma.com
About StockNewsNow.com
StockNewsNow.com is a microcap financial news portal that
features news and insights from the microcap and emerging growth
financial community. StockNewsNow.com is a multimedia destination
hub for information about microcap and emerging growth public and
private companies, market events, news, bulletins, stock quotes,
expert commentary and company profiles that feature SNN-produced
video like SNNLive CEO video interviews, as well as their latest
news and headlines. Users can engage directly and share the
information provided through social media.
Follow the companies YOU want to know more about; read and watch
content from YOUR favorite microcap, emerging growth financial
experts; register to attend financial conferences of YOUR choosing;
find microcap and emerging growth financial professionals that YOU
may be looking for - all here on StockNewsNow.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/rxi-pharmaceuticals-corporation-discusses-competitive-advantage-goals-and-milestones-for-2016-2017-in-new-snnlive-newscast-on-stocknewsnowcom-300368772.html
SOURCE StockNewsNow.com